Revenue growth of 19% year-over-year aligned with expectations, reiterating 2023 revenue and adjusted EBITDA outlook
Awarded PyroThin® contract for European EV commercial truck program with start of vehicle production in early 2024
Executing contract manufacturing strategy to increase capacity and supply Energy Industrial customers in 2024
NORTHBOROUGH, Mass., May 3, 2023 /PRNewswire/ -- Aspen Aerogels, Inc. (NYSE: ASPN) (" Aspen " or the "Company"), a technology leader in sustainability and electrification solutions, today announced financial results for the first quarter of 2023, and discussed recent business developments.
Total revenue for the first quarter of 2023 was $45.6 million, compared to $38.4 million in the first quarter of last year. Net loss was $16.8 million, compared to a net loss of $19.5 million in the first quarter of last year. Net loss per share was $0.24, compared to a net loss per share of $0.59 in the first quarter last year.
Adjusted EBITDA for the first quarter of 2023 was $(13.9) million, compared to $(14.7) million in the first quarter of last year. A reconciliation of non-GAAP Adjusted EBITDA to net loss is provided in the financial schedules that are part of this press release. An explanation of this non-GAAP financial measure is also included below under the heading "Non-GAAP Financial Measures."
First Quarter Highlights and Recent Business Developments
- Total revenue grew 19% year-over-year, and net loss was reduced by $2.7M, or 14% year-over-year
- PyroThin® thermal barrier revenues of $11.7 million, up 53% year-over-year
- Improving margins, with a quarterly gross margin of 11%, a 1,600bps improvement year-over-year, as well as maintaining OPEX flat quarter-over-quarter
- Ended first quarter of 2023 with cash and equivalents of $208 million
- Awarded PyroThin® thermal barrier contract for European electric vehicle ("EV") commercial truck program with start of production expected in early 2024
- Consistent with our strategy and track record of defending our intellectual property rights, filed patent infringement actions against Beerenberg Services AS and related companies seeking injunctive relief and monetary damages
- Aspen's East Providence, Rhode Island plant will primarily serve EV OEM customers with PyroThin® thermal barriers, with additional capacity from planned contract manufacturing supply for Energy Industrial customers
- Right-timing the construction of our planned second aerogel manufacturing facility in Bulloch County, Georgia ("Plant II") to align with the expected ramp of our EV customers
- Maintaining revenue growth targets while accelerating near-term profitability and preserving capital
" Aspen is off to a strong start for the year," commented Don Young, Aspen's President and CEO. "First quarter gross margins reflect the actions that the team is taking to drive towards profitability." Mr. Young added, "2023 is an important commercial year for us, as we expect additional decisions on a significant number of key OEM programs. The new European commercial truck award is a significant achievement and demonstrates the demand for our Pyrothin® products in the emerging commercial EV market. We continue to strengthen our technical and commercial relationships with key customers and are optimistic about our commercial outlook in 2023 and beyond."
Mr. Young noted, "It is important for Aspen to right-time our investment in Plant II to align with our customers and their expected volumes. By leveraging our current plant in Rhode Island and our new aerogel supply arrangements, we believe that we can provide a target revenue capacity of approximately $550 million in 2024. We believe this strategy will enable us to maintain our 2023 and 2024 revenue growth targets while reducing OPEX and CAPEX, generating positive cash flow, preserving our existing capital, and supplying both our EV and Energy Industrial customers."
2023 Financial Outlook
Aspen updates its 2023 full year outlook as follows:
- Total revenue is expected to range between $200 million to $250 million
- Net loss is expected to range between $101.9 million and $91.9 million
- Adjusted EBITDA is expected to range between $(60) million and $(50) million
- Net loss per share is expected to range between $1.46 and $1.31
- CAPEX is reduced from a range of $350 -400 million to a range of $100 -150 million, including $49.4 million invested in the first quarter
The Company's 2023 outlook assumes depreciation and amortization of $22.3 million, stock-based compensation expense of $11.0 million, interest expense of $8.6 million and weighted average shares outstanding of 70.0 million for the full year.
A reconciliation of non-GAAP Adjusted EBITDA to net loss for the 2023 financial outlook is provided in the financial schedules that are part of this press release. An explanation of this non-GAAP financial measure is also included below under the heading "Non-GAAP Financial Measures."
Ricardo C. Rodriguez, Chief Financial Officer and Treasurer noted, "It's time to be increasingly frugal and consider the implications of a high cost of capital environment on every investment. With a larger Energy Industrial order backlog and a growing list of EV customers, our outlook is brighter. Our near-term focus is generating positive cash flows as soon as possible and eliminating our dependence on additional capital to do that."
Mr. Rodriguez added, "We are slowing down our investments, but not our growth."
Aspen may incur, among other items, additional charges, realize gains or losses, incur financing costs or interest expense, or experience other events in 2023, including those related to the planned capacity expansion, supply chain disruptions or further cost inflation, that could cause actual results to vary materially from this outlook. See Special Note Regarding Forward-Looking and Cautionary Statements below.
Conference Call and Webcast Notification
A conference call with Aspen management to discuss first quarter 2023 results and recent business developments will be held at 8:30 am ET on May 4, 2023 . During the call, management will respond to questions concerning, but not limited to, Aspen's financial performance, business conditions, and financial outlook. Management's discussion and responses could contain information that has not been previously disclosed.
Shareholders and other interested parties may call (833) 470-1428 (domestic) or (929) 526-1599 (international) and reference conference ID "635545" to participate in the conference call. In addition, the conference call and an accompanying slide presentation will be available live as a listen-only webcast hosted at the Investors section of Aspen's website, www.aerogel.com.
Following the live event, an archived version of the webcast will be available on Aspen's website for convenient on-demand replay for at least a year. A copy of this press release is posted in the Investors section on Aspen's website.
Non-GAAP Financial Measures
In addition to providing financial measurements based on generally accepted accounting principles in the United States of America ("GAAP"), Aspen provides an additional financial metric that is not prepared in accordance with GAAP ("non-GAAP"). The non-GAAP financial measure included in this press release is Adjusted EBITDA. Management uses this non-GAAP financial measure, in addition to GAAP financial measures, as a measure of operating performance because the non-GAAP financial measure does not include the impact of items that management does not consider indicative of Aspen's core operating performance. In addition, management uses Adjusted EBITDA (i) for planning purposes, including the preparation of Aspen's annual operating budget, (ii) to allocate resources to enhance the financial performance of its business, and (iii) as a performance measure under its bonus plan.
Management believes that this non-GAAP financial measure reflects Aspen's ongoing business in a manner that allows for meaningful comparisons and analysis of trends in its business, as it excludes expenses and gains not reflective of Aspen's ongoing operating results or that may be infrequent and/or unusual in nature. Management also believes that this non-GAAP financial measures provides useful information to investors in understanding and evaluating Aspen's operating results and future prospects in the same manner as management and in comparing financial results across accounting periods and to those of peer companies. This non-GAAP measure may not be comparable to similarly titled measures presented by other companies.
The non-GAAP financial measure does not replace the presentation of Aspen's GAAP financial results and should only be used as a supplement to, not as a substitute for, Aspen's financial results presented in accordance with GAAP. In this press release, Aspen has provided a reconciliation of Adjusted EBITDA to net loss, the most directly comparable GAAP financial measure. Management strongly encourages investors to review Aspen's financial statements and publicly filed reports in their entirety and not rely on any single financial measure.
About Aspen Aerogels, Inc.
Aspen is a technology leader in sustainability and electrification solutions. The Company's aerogel technology enables its customers and partners to achieve their own objectives around the global megatrends of resource efficiency, e-mobility and clean energy. Aspen's PyroThin® products enable solutions to thermal runaway challenges within the electric vehicle ("EV") market. Aspen Battery Materials, the Company's carbon aerogel initiative, seeks to increase the performance of lithium-ion battery cells to enable EV manufacturers to extend the driving range and reduce the cost of EVs. Aspen's Spaceloft® products provide building owners with industry-leading energy efficiency and fire safety. The Company's Cryogel® and Pyrogel® products are valued by the world's largest energy infrastructure companies. Aspen's strategy is to partner with world-class industry leaders to leverage its Aerogel Technology Platform into additional high-value markets. Headquartered in Northborough, Mass., Aspen manufactures its products at its East Providence, RI facilities. For more information, please visit www.aerogel.com.
Special Note Regarding Forward-Looking and Cautionary Statements
This press release and any related discussion contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties that could cause actual results to be materially different from historical results or from any future results expressed or implied by such forward-looking statements, including statements relating to Aspen's 2023 financial outlook. These statements are not historical facts but rather are based on Aspen's current expectations, estimates and projections regarding Aspen's business, operations and other factors relating thereto, including with respect to Aspen's 2023 financial outlook. Words such as "may," "will," "could," "would," "should," "anticipate," "predict," "potential," "continue," "expects," "intends," "plans," "projects," "believes," "estimates," "outlook," "assumes," "targets," "opportunity," and similar expressions are used to identify these forward-looking statements. Such forward-looking statements include statements regarding, among other things, Aspen's expectations about capacity, revenue, revenue capacity, backlog, costs, expenses, profitability, cash flow, gross profit, gross margin, operating margin, net loss, Adjusted EBITDA, Adjusted EBITDA margin and related decreases, improvements, timing, variability or trends; beliefs about higher than expected demand from the EV market and how it may enable a path to profitability, expectations about improvement in ability to absorb fixed costs and reduction of conversion costs as a percentage of sales and the same leading to target gross margins; Aspen's expectations regarding the planned second manufacturing plant in Georgia ("Plant II"), the extended construction and commissioning timeframe for Plant II, Aspen's efforts to manage the construction of Plant II to align with our expectations of demand from EV customers, and the use of contract manufacturers to meet demand from Energy Industrial customers; beliefs about the general strength, weakness or health of Aspen's business; acceleration in demand; beliefs about current or future trends in the energy, energy infrastructure, chemical and refinery, LNG, sustainable building materials, EV thermal barrier, EV battery materials or other markets and the impact of these trends on Aspen's business; beliefs about the strength, effectiveness, productivity, costs, profitability or other fundamentals of Aspen's business; beliefs about the role of Aspen's technology and opportunities in the electric vehicle market; beliefs about Aspen's ability to provide and deliver products and services to electric vehicle customers; beliefs about content per vehicle, revenue, costs, expenses, profitability, investments or cash flow associated with Aspen's electric vehicle opportunities, including the EV thermal barrier business; beliefs about revenue growth and profitability; beliefs about the performance of PyroThin® including its ability to mitigate the propagation of thermal runaway in electric vehicles; beliefs about Aspen's ability to expand the market for PyroThin®, to achieve design wins, to commence shipments of production parts, and to become an industry standard solution for thermal runaway management; beliefs about Aspen's thermal barrier design, prototype, quoting and assembly activities; and expectations about the cost of the capital projects, including Plant II; . All such forward-looking statements are based on management's present expectations and are subject to certain factors, risks and uncertainties that may cause actual results, outcome of events, timing and performance to differ materially from those expressed or implied by such statements. These risks and uncertainties include, but are not limited to, the following: inability to execute the growth plan, inability to complete construction and commissioning the Plant II and to do so at a cost consistent with Aspen's estimates and aligned with Aspen's expectations of demand from our EV customers; the right of EV thermal barrier customers to cancel contracts with Aspen at any time and without penalty; any costs, expenses, or investments incurred by Aspen in excess of projections used to develop pricing under the contracts with EV thermal barrier customers; Aspen's inability to create customer or market opportunities for, including PyroThin®; any other battery performance and safety products, battery materials or for other new products developed from Aspen's aerogel technology; any disruption or inability to achieve expected capacity levels in any of the three existing production lines in East Providence, RI or the Mexico assembly facility or at any contract manufacturer; any failure to enforce any of Aspen's patents; the general economic conditions and cyclical demands in the markets that Aspen serves; and the other risk factors discussed under the heading "Risk Factors" in Aspen's Annual Report on Form 10-K for the year ended December 31, 2022 and filed with the Securities and Exchange Commission ("SEC") on March 16, 2023, as well as any updates to those risk factors filed from time to time in Aspen's subsequent periodic and current reports filed with the SEC. All statements contained in this press release are made only as of the date of this press release. Aspen does not intend to update this information unless required by law.
ASPEN AEROGELS, INC. | ||||||||
Condensed Consolidated Balance Sheets | ||||||||
(Unaudited and in thousands) | ||||||||
March 31, | December 31, | |||||||
2023 | 2022 | |||||||
(In thousands, except | ||||||||
Assets | ||||||||
Current assets: | ||||||||
Cash and cash equivalents | $ | 207,539 | $ | 281,335 | ||||
Restricted cash | 629 | 1,226 | ||||||
Accounts receivable, net | 47,280 | 57,350 | ||||||
Inventories | 27,007 | 22,538 | ||||||
Prepaid expenses and other current assets | 13,581 | 7,236 | ||||||
Total current assets | 296,036 | 369,685 | ||||||
Property, plant and equipment, net | 312,068 | 259,223 | ||||||
Operating lease right-of-use assets | 10,218 | 11,990 | ||||||
Other long-term assets | 2,410 | 2,518 | ||||||
Total assets | $ | 620,732 | $ | 643,416 | ||||
Liabilities and Stockholders' Equity | ||||||||
Current liabilities: | ||||||||
Accounts payable | $ | 52,822 | $ | 54,728 | ||||
Accrued expenses | 9,763 | 16,003 | ||||||
Deferred revenue | 3,974 | 5,846 | ||||||
Operating lease liabilities | 2,267 | 2,368 | ||||||
Total current liabilities | 68,826 | 78,945 | ||||||
Convertible note - related party | 106,416 | 103,580 | ||||||
Operating lease liabilities long-term | 12,948 | 13,456 | ||||||
Total liabilities | 188,190 | 195,981 | ||||||
Stockholders' equity: | ||||||||
Total stockholders' equity | 432,542 | 447,435 | ||||||
Total liabilities and stockholders' equity | $ | 620,732 | $ | 643,416 | ||||
ASPEN AEROGELS, INC. | ||||||||
Consolidated Statements of Operations | ||||||||
(Unaudited and in thousands, except share and per share data) | ||||||||
Three Months Ended | ||||||||
March 31, | ||||||||
2023 | 2022 | |||||||
(In thousands, except | ||||||||
Revenue | $ | 45,586 | $ | 38,407 | ||||
Cost of revenue | 40,500 | 40,195 | ||||||
Gross profit (loss) | 5,086 | (1,788) | ||||||
Operating expenses: | ||||||||
Research and development | 4,099 | 3,592 | ||||||
Sales and marketing | 7,713 | 6,018 | ||||||
General and administrative | 12,182 | 7,226 | ||||||
Total operating expenses | 23,994 | 16,836 | ||||||
Loss from operations | (18,908) | (18,624) | ||||||
Other income (expense) | ||||||||
Interest expense, convertible note - related party | (275) | (819) | ||||||
Interest income (expense), net | 2,387 | (41) | ||||||
Total other income (expense), net | 2,112 | (860) | ||||||
Net loss | $ | (16,796) | $ | (19,484) | ||||
Net loss per share: | ||||||||
Basic and diluted | $ | (0.24) | $ | (0.59) | ||||
Weighted-average common shares outstanding: | ||||||||
Basic and diluted | 69,162,739 | 32,940,040 | ||||||
Analysis of Cash Flow
The following table summarizes our cash flows for the periods indicated.
Three Months Ended March 31, | ||||||||
2023 | 2022 | |||||||
($ in thousands) | ||||||||
Net cash provided by (used in): | ||||||||
Operating activities | $ | (24,651) | $ | (22,829) | ||||
Investing activities | (49,378) | (14,504) | ||||||
Financing activities | (364) | 165,946 | ||||||
Net (decrease) increase in cash | (74,393) | 128,613 | ||||||
Cash, cash equivalents and restricted cash at beginning of period | 282,561 | 76,564 | ||||||
Cash, cash equivalents, restricted cash and restricted cash equivalents at end of period | $ | 208,168 | $ | 205,177 | ||||
Square Foot Operating Metric
The following chart sets forth Energy Industrial product shipments in square feet associated with recognized revenue.
Three Months Ended | ||||||||
March 31, | ||||||||
2023 | 2022 | |||||||
(In thousands) | ||||||||
Energy Industrial product shipments in square feet | 8,183 | 8,163 | ||||||
Reconciliation of Non-GAAP Financial Measures
The following tables present a reconciliation of the non-GAAP financial measure included in this press release to the most directly comparable GAAP measure:
Reconciliation of Adjusted EBITDA to Net loss
We define Adjusted EBITDA as net income (loss) before interest expense, taxes, depreciation, amortization, stock-based compensation expense and other items, which occur from time to time and which we do not believe are indicative of our core operating performance.
For the three months ended March 31, 2023 and 2022:
Three Months Ended | ||||||||
March 31, | ||||||||
2023 | 2022 | |||||||
(In thousands) | ||||||||
Net loss | $ | (16,796) | $ | (19,484) | ||||
Depreciation and amortization | 2,704 | 2,129 | ||||||
Stock-based compensation | 2,267 | 1,828 | ||||||
Interest (income) expense | (2,112) | 860 | ||||||
Adjusted EBITDA | $ | (13,937) | $ | (14,667) | ||||
For the 2023 full year financial outlook:
Year Ending | ||||||||
December 31, 2023 | ||||||||
Low | High | |||||||
(In thousands) | ||||||||
Net loss | $ | (101,900) | $ | (91,900) | ||||
Depreciation and amortization | 22,300 | 22,300 | ||||||
Stock-based compensation | 11,000 | 11,000 | ||||||
Interest expense, net | 8,600 | 8,600 | ||||||
Adjusted EBITDA | $ | (60,000) | $ | (50,000) | ||||
SOURCE Aspen Aerogels, Inc.
